Shashwat Sharad Selected Research

Neoplasms (Cancer)

1/2020	Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer.
1/2020	PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer.
1/2020	Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers.
12/2019	Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer.
10/2019	Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
1/2017	ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development.
4/2016	Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.
8/2014	ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity.
6/2014	Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shashwat Sharad Research Topics

Disease

12	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2014
9	Neoplasms (Cancer) 01/2020 - 06/2014
4	Carcinogenesis 01/2020 - 06/2014
2	COVID-19 09/2021 - 01/2021
2	Inflammation (Inflammations) 08/2020 - 01/2013
1	Body Weight (Weight, Body) 08/2020
1	Fibrosis (Cirrhosis) 08/2020
1	Hyperglycemia 08/2020
1	Obesity 08/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2020
1	Dyslipidemias (Dyslipidemia) 08/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Bacterial Infections (Bacterial Infection) 12/2019
1	Wounds and Injuries (Trauma) 05/2016
1	Melanoma (Melanoma, Malignant) 01/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2013
1	Vitiligo 01/2013
1	Skin Diseases (Skin Disease) 01/2013
1	Cataract (Cataracts) 05/2009
1	Eye Diseases (Eye Disease) 05/2009
1	Opioid-Related Disorders (Opiate Addiction) 12/2007
1	Substance-Related Disorders (Drug Abuse) 12/2007

Drug/Important Bio-Agent (IBA)

6	AndrogensIBA 01/2020 - 08/2014
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2014
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2017
4	Androgen Receptors (Androgen Receptor)IBA 10/2019 - 06/2014
3	Hormones (Hormone)IBA 01/2020 - 06/2015
3	Protein Isoforms (Isoforms)IBA 01/2020 - 12/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2019
2	Messenger RNA (mRNA)IBA 12/2019 - 06/2014
2	CurcuminIBA 10/2019 - 01/2013
1	Antiviral Agents (Antivirals)IBA 09/2021
1	MESKIBA 08/2020
1	Orlistat (Xenical)FDA Link 08/2020
1	CholesterolIBA 08/2020
1	Glucose (Dextrose)FDA LinkGeneric 08/2020
1	LipidsIBA 08/2020
1	Triglycerides (Triacylglycerol)IBA 08/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	PhytochemicalsIBA 05/2016
1	MicroRNAs (MicroRNA)IBA 04/2016
1	NAD (NADH)IBA 04/2016
1	Sirtuin 1IBA 04/2016
1	Carrier Proteins (Binding Protein)IBA 06/2015
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2015
1	Monoclonal AntibodiesIBA 08/2014
1	EpitopesIBA 08/2014
1	Amino Acids FDA Link 08/2014
1	NF-kappa B (NF-kB)IBA 01/2013
1	Free RadicalsIBA 01/2013
1	gamma-CrystallinsIBA 05/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 12/2007

Therapy/Procedure

3	Therapeutics 01/2021 - 08/2014
1	Oral Hygiene (Dental Hygiene) 09/2021
1	Lasers (Laser) 12/2019